QuickView for KMT2D;jsessionid=67F25248A51DDD3E09748DEB17D7BA58 (gene)

1. Blood DNA methylation provides an accurate biomarker of KMT2B-related dystonia and predicts onset.
2. Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders.
3. A New Pathologic KMT2B Variant Associated with Childhood Onset Dystonia Presenting as Variable Pheno…
4. A novel synonymous KMT2B variant in a patient with dystonia causes aberrant splicing.
5. A severe case of status dystonicus caused by a de novo KMT2B missense mutation.

There were no clinical trials for KMT2D;jsessionid=67F25248A51DDD3E09748DEB17D7BA58